Daniel Koppelkamm, Cfa Email and Phone Number
Daniel Koppelkamm, Cfa work email
- Valid
- Valid
Daniel Koppelkamm, Cfa personal email
- Valid
Active investor in young technology companies that have a positive impact on planet and society. Founder of Convergence Partners, a HealthTech venture capital firm focused on healthcare sectors with large unmet needs, such as Brain and Womens Health. Previously, co-initiator of one of Europe`s first dedicated CleanTech funds. Global citizen who is passionate about linking cultures for success. Currently, we have a particular interest in mental & neurological health, technodelics-, longevity-and womens health-related technologies and business models. I am also excited by the disruption that blockchain technology and computational biology are bringing to healthcare.
Convergence Partners Ag
View- Website:
- convergence-partners.ch
- Employees:
- 17
-
Founder And Managing PartnerConvergence Partners AgCanton Of Zug, Switzerland
-
Founder & Managing PartnerConvergence Partners Ag Jul 2018 - PresentZug, Zug, ChConvergence Partners is a pan-European venture capital firm focused on investments in Mental & Brain Health, Womens Health and AI-driven drug discovery. Convergence acts as an active sparring partner to founders, supporting their international scale-up in the worlds largest healthcare markets. Convergence is currently raising a EUR 100m Brain Health Fund.
-
Business MentorTech4Eva - The Global Femtech Accelerator Mar 2024 - PresentLausanne, Vd, Ch -
Co-Founder & Council MemberAguilacondor Foundation Jan 2024 - PresentZurich, ChACF’s mission is to protect LIFE by amplifying & safeguarding ancient indigenous wisdom and cultures for the elevation of human consciousness. -
Co-Founder & DirectorConvergence Holding Limited Sep 2021 - PresentCHL manages all start-up cross-border acceleration activities of Convergence Partners.
-
InvestorCopresence Sep 2023 - PresentZurich, ChCopresence is an AI and software platform that offers a digital avatar solution for the connected world. -
InvestorClerkenwell Health Aug 2022 - PresentLondon, GbClerkenwell Health is a leading psychedelic specialty CRO offering specialist trial design, regulatory submission and trial delivery services. -
InvestorInterax Biotech Jul 2022 - PresentVilligen, ChInterAx has commercialised a drug discovery and optimisation technology platform to go beyond target identification and ligand discovery. It is connecting AI and cell signalling to design drugs triggering a precisely defined cell pathway modulation. InterAx is also developing own drug assets in neurology and womens health. -
Investor & AdvisorSensit! (Formerly Feelbelt) Jul 2022 - PresentPotsdam, Brandenburg, DeSensit! is a fast growing haptics technology leader in converting sound into touch - "awakening" the digital world. Application areas include Mental Health therapy, Gaming, Virtual Reality and the Metaverse. -
InvestorB-Rayz Jun 2022 - PresentSchlieren, Zurich, Chb-rayZ is a medical AI company that supports the daily work of the radiologist in mammography with a real-time assessment of image quality and breast density. -
InvestorNeotiv Oct 2021 - PresentMagdeburg, Saxony-Anhalt, Deneotiv develops unique cognitive tests – embedded in a digital platform – to enable early medical assessment and follow-up of memory problems in the context of Alzheimer's disease. -
InvestorNeurocare Group Ag Jul 2021 - PresentMunich, Germany, Deutschland, DeneuroCare is active in the fast growing market for neurotherapy, a non-invasive option for mental health, pain and rehabilitation using neuromodulation technologies integrated with psychotherapy. -
InvestorOxford Endovascular Ltd. Feb 2021 - PresentOxford, GbOxford Endovascular is a spin out from Oxford University developing technology to prevent brain haemorrhage. OxiFlow™️ is a novel, next generation flow-diverter, laser-cut from nitinol that diverts blood flow away from intracranial aneurysms at risk of rupture. -
InvestorGedea Biotech Ab Jul 2020 - PresentLund, Skane, SeGedea Biotech is a medical nutrition company focused on developing an antibiotic-free, safe and effective treatment of vaginal fungal infections. -
InvestorSom Biotech Jun 2017 - PresentBarcelona, EsSOM Biotech is a medical AI company focused on the accelerated discovery and development of therapies for neuro-degenerative orphan diseases through a proprietary AI-based drug discovery technology. -
Director, Board MemberMountain Cleantech Co-Invest Sarl Sep 2014 - Nov 2021Cleantech co-investment vehicle with a leading Spanish family office.
-
Principal, General Partner & Investment Committee MemberJadeberg Partners Ag Apr 2009 - Nov 2018Baar, Schweiz, ChHightech venture capital firm focused on early growth-stage companies in the D-A-CH region. -
Investment ManagerMan Group Sep 2003 - Mar 2009London, London, GbVarious investment functions focused on technology investing. -
Business AnalystIntel Corporation Jul 2000 - Aug 2001Santa Clara, California, UsIntel Inside® ProgramIntel Capital
Daniel Koppelkamm, Cfa Skills
Daniel Koppelkamm, Cfa Education Details
-
Bayes Business SchoolEuropean Business -
Cfa InstituteChartered Financial Analyst
-
Caia AssociationChartered Alternative Investment Analyst
-
Bayes Business SchoolBusiness Studies
Frequently Asked Questions about Daniel Koppelkamm, Cfa
What company does Daniel Koppelkamm, Cfa work for?
Daniel Koppelkamm, Cfa works for Convergence Partners Ag
What is Daniel Koppelkamm, Cfa's role at the current company?
Daniel Koppelkamm, Cfa's current role is Founder and Managing Partner.
What is Daniel Koppelkamm, Cfa's email address?
Daniel Koppelkamm, Cfa's email address is da****@****ail.com
What schools did Daniel Koppelkamm, Cfa attend?
Daniel Koppelkamm, Cfa attended Bayes Business School, Cfa Institute, Caia Association, Bayes Business School.
What are some of Daniel Koppelkamm, Cfa's interests?
Daniel Koppelkamm, Cfa has interest in Children, Skiing, China Networking, Environment, Education, Impact Investing, Wine, Fine Dining, Fitness, Science And Technology.
What skills is Daniel Koppelkamm, Cfa known for?
Daniel Koppelkamm, Cfa has skills like Private Equity, Venture Capital, Alternative Investments, Hedge Funds, Investments, Equity Research, Funding, Corporate Finance, Finance, Asset Management, Fundraising, Mergers And Acquisitions.
Who are Daniel Koppelkamm, Cfa's colleagues?
Daniel Koppelkamm, Cfa's colleagues are Jenny Hao, Michelle (Xingyue) Chen, Nicolas L. Kiep.
Free Chrome Extension
Find emails, phones & company data instantly
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial